Abstract:You have accessJournal of UrologyKidney Cancer: Localized: Surgical Therapy II (MP37)1 Apr 2019MP37-14 MODIFIED ROBOT-ASSISTED SIMPLE ENUCLEATION WITH SINGLE LAYER RENORRHAPHY TECHNIQUE VERSUS STANDARD ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH A RENAL NEPHROMETRY SCORE ≥7 Qun Lu*, Xiaozhi Zhao, Changwei Ji, Guangxiang Liu, Linfeng Xu, Shiwei Zhang, Xiaogong Li, Gutian Zhang, and Hongqian Guo Qun Lu*Qun Lu* More articles by this author , Xiaozhi ZhaoXiaozhi Zhao More articles by this author , Changwei JiChangwei Ji More articles by this author , Guangxiang LiuGuangxiang Liu More articles by this author , Linfeng XuLinfeng Xu More articles by this author , Shiwei ZhangShiwei Zhang More articles by this author , Xiaogong LiXiaogong Li More articles by this author , Gutian ZhangGutian Zhang More articles by this author , and Hongqian GuoHongqian Guo More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000556044.64182.31AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Nephron-sparing surgery is the gold standard treatment for localized renal masses. Simple enucleation has proven to be oncologically safe. In this study, we used our large institutional experience to compare perioperative results and early oncological outcomes with modified robot-assisted simple enucleation (MRASE) and robot-assisted partial nephrectomy (RAPN) for moderately or highly complex tumours (defined as RENAL nephrometry score ≥7). METHODS: We evaluated 320 consecutive patients who underwent MRASE or RAPN for renal tumors in our institution from September 2014 to July 2018 in terms of perioperative pathologic and oncologic outcome variables. In simple enucleation, the surgeon used the pseudocapsule as the anatomical landmark to enucleate the tumor by blunt dissection, with no visible rim of normal parenchyma. The single layer suture technique was performed for renal reconstruction. RESULTS: In total, 223 patients underwent MRASE and 97 underwent RAPN. Demographic characteristics were similar in the two groups. Mean operative time was 182.0 and 196.0 min, respectively (p=0.024). Warm ischemic time was significantly lower in the MRASE than RAPN group (22.2 vs 25.2 min; p=0.008). The estimated blood loss was similar (p=0.067). Tumor bed suturing was performed in 9.4% and 89.7% of MRASE and RAPN cases (P=0.000). No hilar clamping was performed in 19 (8.5%) MRASE patients and 4 (4.1%) RAPN patients (p=0.190). The rates of intraoperative and postoperative complications were similar. The incidence of positive surgical margins was comparable between the MRASE and RAPN groups (1.8% and 5.2%, p= 0.192). Recurrence did not differ between the 2 groups: 8 (3.6%) MRASE patients and 5 (5.2%) RAPN patients (p=0.730) during follow-up. CONCLUSIONS: In patients with moderately or highly complex tumours, MRASE may confer shorter operative time, warm ischemic time and almost no need for tumor bed suturing than RAPN, with similar oncologic outcomes. Source of Funding: none Nanjing, China, People’s Republic of© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e529-e530 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Qun Lu* More articles by this author Xiaozhi Zhao More articles by this author Changwei Ji More articles by this author Guangxiang Liu More articles by this author Linfeng Xu More articles by this author Shiwei Zhang More articles by this author Xiaogong Li More articles by this author Gutian Zhang More articles by this author Hongqian Guo More articles by this author Expand All Advertisement PDF downloadLoading ...

Trifecta Outcomes of Modified Robot-Assisted Simple Enucleation and Standard Robot-Assisted Partial Nephrectomy for Treating Clinical T1b Renal Cell Carcinoma.

[A Rational Analysis of the Commonly Used Renal Tumor Scoring Systems in Predicting Surgical Outcomes of Cystic Renal Masses].

Trifecta Outcomes of Robot-Assisted Partial Nephrectomy Using the New HugoTM RAS System Versus Laparoscopic Partial Nephrectomy

Comparison of Trifecta and Pentafecta Outcomes across 3 Surgical Modalities of Partial Nephrectomy (PN) - Open, Lap, and Robotic

Robot-assisted Simple Enucleation Versus Standard Robot-assisted Partial Nephrectomy for Low- or Intermediate-complexity, Clinical T1 Renal Tumors: A Randomized Controlled Noninferiority Trial.

Impact of renal sinus protrusions on achieving trifecta in robot-assisted partial nephrectomy

Assessing Trifecta and Pentafecta Success Rates between Robot-Assisted vs. Open Radical Cystectomy: A Propensity Score-Matched Analysis

Utilization of a three-dimensional printed kidney model for favorable TRIFECTA achievement in early experience of robot-assisted partial nephrectomy

Retroperitoneoscopic Partial Nephrectomy for Moderately Complex Ventral Hilar Tumors: Surgical Technique and Trifecta Outcomes from a Single Institution in China.

MP37-14 MODIFIED ROBOT-ASSISTED SIMPLE ENUCLEATION WITH SINGLE LAYER RENORRHAPHY TECHNIQUE VERSUS STANDARD ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH A RENAL NEPHROMETRY SCORE ≥7

MP42-04 MODIFIED ROBOT-ASSISTED SIMPLE ENUCLEATION WITH SINGLE LAYER RENORRHAPHY TECHNIQUE VERSUS STANDARD ROBOT-ASSISTED PARTIAL NEPHRECTOMY FOR TREATING LOCALIZED RENAL CELL CARCINOMA

Three‐dimensional computed tomography‐based resection process map for robot‐assisted partial nephrectomy: propensity score matching of a single‐center retrospective study

Impacts of completely endophytic renal masses on perioperative, oncologic, and functional outcomes in robot-assisted partial nephrectomy: a systematic review and meta-analysis

Functional and Oncologic Outcomes of Robot-Assisted Simple Enucleation with and Without Renal Arterial Cold Perfusion in Complex Renal Tumors: A Propensity Score-Matched Analysis

The clinical application value of mixed reality in robotic laparoscopic partial nephrectomy

Tumor Enucleation Vs. Partial Nephrectomy for T1 Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis

Perioperative, oncologic, and functional outcomes of robot-assisted partial nephrectomy for special types of renal tumors (hilar, endophytic, or cystic): an evidence-based analysis of comparative outcomes

Percutaneous thermal ablation for cT1 renal mass in solitary kidney: A multicenter trifecta comparative analysis versus robot-assisted partial nephrectomy

Open versus robot-assisted radical cystectomy: pentafecta and trifecta achievement comparison from a randomised controlled trial

Impacts of complete endophytic renal tumors on surgical, functional, and oncological outcomes of robot-assisted partial nephrectomy